Locoregional IL-2 immunotherapy of bladder cancer.
Santoni
A
A
Department of Experimental Medicine, University of Rome La Sapienza, Italy.
Velotti
F
F
Giuffrida
A
A
Santoni
G
G
Piccoli
M
M
D000283:Administration, Intravesical; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007167:Immunotherapy; D007261:Infusions, Intra-Arterial; D015552:Injections, Intralesional; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000628:therapy*
D000970:Antineoplastic Agents; D007376:Interleukin-2